NYSE (USA) TSX (CANADA)

Directory of Stock Market Company

This site is a directory of Stock Market Company in USA and Canada. Each company page contains a description, stock quote, news and much more. You have also access to the best stock market game on the web.

Search into NYSE and TSX
by quote, company name or key word

facebooktwitterlinkedin
Mail

ACAD - ACADIA Pharmaceuticals Inc

ACADIA Pharmaceuticals Inc., incorporated in 1993, is a biopharmaceutical company focused on the development and commercialization of small molecule drugs for the treatment of central nervous system disorders. Its pipeline consists of four product candidates including pimavanserin, which is in Phase-III development as a treatment for Parkinson’s disease psychosis. It ha","NYSE, Nasdaq, S&P, trading, US market, Asian market, Dow Jones, FTSE, DJIA, DAX, stocks, bonds, shares","Connect to the most current information on stocks and bonds on Reuters.com. What you need to know now about NYSE, Dow Jones, S&P, and Nasdaq at Reuters.com"

# ACADhart

ACADIA Pharmaceuticals Inc News


Pre-Market Movers (Osiris Therapeutics, Morgan Stanley, Salesforce.com, First ...
International Business Times - May 18, 2012
By Satya Nagendra Padala: Subscribe to Satya's RSS feed The companies whose shares are moving in pre-market trading on Friday are: ACADIA Pharmaceuticals, Osiris Therapeutics, Morgan Stanley, Salesforce.

Review: Pfizer's Phase III Study Didn't Meet Primary Endpoint; Boston ...
The Mumbai Times - May 18, 2012
Rite Aid Corp (NYSE:RAD) shares were trading at $1.23 while reporting down 7.52% from yesterdays close. The 4 analysts offering 12-month price forecasts for Rite Aid Corp have a median target of 1.95, with a high estimate of 2.25 and a low estimate of ...

Premarket Movers (Acadia Pharmaceuticals, Citigroup, Fossil, Dendreon ...
International Business Times - May 16, 2012
By Bhaskar Prasad: Subscribe to Bhaskar's RSS feed The companies whose shares are moving in premarket trade Wednesday are: Acadia Pharmaceuticals Citigroup Inc., Fossil Inc., Dendreon Corp.

ACADIA Pharmaceuticals to Webcast Educational Program on Parkinson's Disease ...
EON: Enhanced Online News (press release) - May 16, 2012
SAN DIEGO--(EON: Enhanced Online News)--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, ...

Pfizer's Phase III Study Didn't Meet Primary Endpoint; Boston Scientific ...
BioMedReports (subscription) - May 16, 2012
By Staff and Wire Reports Below is a look at some of the headlines for companies that made news in the healthcare sector on May 15, 2012.

ACADIA Pharmaceuticals to Webcast Educational Program on Parkinson's Disease ...
MarketWatch (press release) - May 15, 2012
SAN DIEGO, May 15, 2012 (BUSINESS WIRE) -- ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) , a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, ...

Pre-Market Movers (Acadia Pharmaceuticals, Infosys, UBS AG, JPMorgan Chase ...
International Business Times - May 15, 2012
By Bhaskar Prasad: Subscribe to Bhaskar's RSS feed The companies whose shares are moving in pre-market trade Tuesday are: Acadia Pharmaceuticals Inc, Infosys Ltd, UBS AG, JPMorgan Chase & Co, Avon Products, Inc, The Home Depot Inc and Nokia Corporation ...

Pre-Market Movers (JPMorgan Chase, Alcoa, Avon, Symantec, Micron Technology ...
International Business Times - May 14, 2012
By Satya Nagendra Padala: Subscribe to Satya's RSS feed The companies whose shares are moving in pre-market trade Monday are: Acadia Pharmaceuticals, Avon Products, Chesapeake Energy Corp, Micron Technology, Ancestry.

ACADIA Pharmaceuticals Reports First Quarter 2012 Financial Results
TheStreet.com (press release) - May 9, 2012
By Business Wire 05/08/12 - 04:01 PM EDT ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, ...

ACADIA Pharmaceuticals Reports First Quarter 2012 Financial Results
MarketWatch (press release) - May 8, 2012
SAN DIEGO, May 08, 2012 (BUSINESS WIRE) -- ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) , a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, ...

NYSE Media Coverage Selection of the best articles found in your favorit medias

Next Company >>